Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PYPD | US
0
0%
Healthcare
Biotechnology
30/06/2024
17/10/2024
3.43
3.43
3.49
3.43
PolyPid Ltd. a clinical-stage pharmaceutical company develops manufactures and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100 which helps in the prevention of sternal (bone) surgical site infections (SSIs) as well as for the prevention of abdominal (soft tissue) SSIs. It is also developing OncoPLEX for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva Israel.
View LessNegative Momentum (Declining Price)
Price Below SMA10D
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
25.2%1 month
35.9%3 months
56.3%6 months
59.6%-
-
14.92
6.89
0.56
-0.36
-
-
-21.95M
23.60M
23.60M
-
-
-
-
-496.62
1.89
0.13
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.42
Range1M
0.43
Range3M
1.47
Rel. volume
0.43
Price X volume
7.65K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
SABS | SABS | Biotechnology | 2.76 | 25.47M | -11.25% | n/a | 11.58% |
Tonix Pharmaceuticals Holding Corp | TNXP | Biotechnology | 0.1794 | 25.11M | 12.83% | n/a | 21.99% |
Iterum Therapeutics plc | ITRM | Biotechnology | 1.09 | 24.75M | 5.83% | n/a | -198.11% |
iBio Inc | IBIO | Biotechnology | 2.85 | 24.62M | 0.00% | n/a | 20.92% |
CytoMed Therapeutics Limited Ordinary Shares | GDTC | Biotechnology | 2.1301 | 24.58M | 2.41% | n/a | 3.98% |
Caladrius Biosciences Inc | LSTA | Biotechnology | 2.94 | 24.46M | 0.00% | n/a | 0.58% |
Bolt Technology Corp | BOLT | Biotechnology | 0.638 | 24.41M | -0.31% | n/a | 22.00% |
RenovoRx Inc. Common Stock | RNXT | Biotechnology | 1 | 23.99M | -1.46% | n/a | 0.00% |
BioXcel Therapeutics Inc | BTAI | Biotechnology | 0.57 | 23.22M | -1.72% | n/a | -139.46% |
ImmunoCellular Therapeutics Ltd | IMUC | Biotechnology | 0.138 | 23.09M | 0.00% | 0.02 | -82.78% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.6 | 19.19M | 0.80% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 0.98 | 17.70M | -3.92% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.36 | 0.53 | Cheaper |
Ent. to Revenue | - | 4,005.99 | - |
PE Ratio | - | 40.42 | - |
Price to Book | 14.92 | 15.30 | Par |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 56.30 | 72.92 | Lower Risk |
Debt to Equity | 6.89 | -1.24 | Expensive |
Debt to Assets | 0.56 | 0.25 | Expensive |
Market Cap | 23.60M | 3.78B | Emerging |